Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Wang, Yu  [Clear All Filters]
2019
Hu, Q., Huang, L., Zhao, C., Shen, Y., Zheng, X.-F., Wang, Y., Zhou, C.-H., and Wu, Y.-Q. (2019). Ca-PKCα-ERK1/2 signaling pathway is involved in the suppressive effect of propofol on proliferation of neural stem cells from the neonatal rat hippocampus.Brain Res Bull.
Ma, R., Huang, X.-J., Xu, L.-P., Liu, K.-Y., Zhang, X.-H., Yan, C.-H., Han, W., Wang, F.-R., Chen, Y.-H., Chen, H., et al. (2019). Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies.Biol Blood Marrow Transplant.
Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., Wang, J.-Z., et al. (2019). Corrigendum to 'Interferon α: A potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation' [Biology of Blood and Marrow Transplantation 21/11 (2015) 19.Biol Blood Marrow Transplant.
Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., Wang, J.-Z., et al. (2019). Corrigendum to 'Interferon-α is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study' [Biology of Blood and Marrow Transplantation 23/8 (.Biol Blood Marrow Transplant.
Yan, C.-H., Liu, Q.-F., Wu, D.-P., Zhang, X., Xu, L.-P., Zhang, X.-H., Wang, Y., Huang, H., Bai, H., Huang, F., et al. (2019). Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor.Biol Blood Marrow Transplant.
Yu, X., Cao, X., Yan, H., Luo, X.-Y., Zhao, X., Sun, Y., Wang, Y., Xu, L., Zhang, X., Chang, Y., et al. (2019). Delay expression of NKp30 on NK cells correlates with long-term mycophenolate mofetil treatment and higher EBV viremia post allogenic hematological stem cells transplantation.Clin Immunol.
Zhang, J., Zhao, J., Chen, Y., Shi, H., Huang, X., Wang, Y., Wang, Y., Wei, Y., Xue, W., and Han, J. (2019). Effect of mGluR7 on proliferation of human embryonic neural stem cells.Medicine (Baltimore)98, e14683.
Jing, L., Ruan, Z., Sun, H., Li, Q., Han, L., Huang, L., Yu, S., Wang, Y., Guo, H., and Jiao, M. (2019). Epithelial-mesenchymal transition induced cancer-stem-cell-like characteristics in hepatocellular carcinoma.J Cell Physiol.
Zhao, X.-Y., Pei, X.-Y., Chang, Y.-J., Yu, X.-X., Xu, L.-P., Wang, Y., Zhang, X.-H., Liu, K.-Y., and Huang, X.-J. (2019). First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation.Clin Infect Dis.
Zhang, Y.-Y., Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., et al. (2019). FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.Bone Marrow Transplant.
Wen, Q., Kong, Y., Zhao, H.-Y., Zhang, Y.-Y., Han, T.-T., Wang, Y., Xu, L.-P., Zhang, X.-H., and Huang, X.-J. (2019). G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant.
Wang, Y., Tatham, M.H., Schmidt-Heck, W., Swann, C., Singh-Dolt, K., Meseguer-Ripolles, J., Lucendo-Villarin, B., Kunath, T., Rudd, T.R., Smith, A.J.H., et al. (2019). Multiomics Analyses of HNF4α Protein Domain Function during Human Pluripotent Stem Cell Differentiation.Iscience16, 206-217.
Hu, L., Wang, Q., Zhang, X., Xu, L., Wang, Y., Yan, C., Chen, H., Chen, Y., Liu, K., Wang, H., et al. (2019). Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation.Front Med.
Wang, X.-Y., Fan, Q.-Z., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., et al. (2019). The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia.Cytometry B Clin Cytom.
Fu, H., Zhao, J., Xu, L., Liu, K., Wang, Y., Chen, H., Han, W., Wang, J., Wang, F., Huang, X., et al. (2019). Reduced β2-GPI is associated with increased platelet aggregation and activation in patients with prolonged isolated thrombocytopenia after allo-HSCT.Sci China Life Sci.
Xuan, L., Wang, Y., Chen, J., Jiang, E., Gao, L., Wu, B., Deng, L., Liang, X., Huang, F., Fan, Z., et al. (2019). Sorafenib therapy is associated with improved outcomes for FLT3-ITD AML relapsing after allo-HSCT.Biol Blood Marrow Transplant.
2018
Zhou, J., Wang, Y., Liu, Y., Zeng, H., Xu, H., and Lian, F. (2018). Adipose derived mesenchymal stem cells alleviated osteoarthritis and chondrocyte apoptosis through autophagy inducing.J Cell Biochem.
Xue, Y.-J., Cheng, Y.-F., Lu, A.-D., Wang, Y., Zuo, Y.-X., Yan, C.-H., Wu, J., Sun, Y.-Q., Suo, P., Chen, Y.-H., et al. (2018). Allogeneic hematopoietic stem cell transplantation, especially haploidentical HSCT, may improve long-term survival for high-risk pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era.Biol Blood Marrow Transplant.
Liu, Y., Huang, X., Fei, Q., Xu, L., Zhang, X., Liu, K., Chen, Y., Chen, H., and Wang, Y. (2018). Comparison analysis between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission.Sci China Life Sci.
Song, Y., Zhao, H.-Y., Lyu, Z.-S., Cao, X.-N., Shi, M.-M., Wen, Q.-, Tang, F.-F., Wang, Y., Xu, L.-P., Zhang, X.-H., et al. (2018). Dysfunctional bone marrow mesenchymal stem cells in patients with poor graft function after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Chang, Y.-J., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., Yan, C.-H., et al. (2018). Effects of low-dose glucocorticoid prophylaxis on chronic GVHD and GVHD-free, relapse-free survival after haploidentical transplantation: long-term follow-up of a controlled, randomized open-label trial.Biol Blood Marrow Transplant.
Zhao, C., Zhao, Y., Zhang, J., Lu, J., Chen, L., Zhang, Y., Ying, Y., Xu, J., Wei, S., and Wang, Y. (2018). HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control.Mol Ther Nucleic Acids13, 208-219.
Yan, C.-H., Wang, Y., Mo, X.-D., Sun, Y.-Q., Wang, F.-R., Fu, H.-X., Chen, Y., Han, T.-T., Kong, J., Cheng, Y.-F., et al. (2018). Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation.Clin Infect Dis67, S162-S173.
Liu, Z., Chang, H., Hou, Y., Wang, Y., Zhou, Z., Wang, M., Huang, Z., and Yu, B. (2018). Lentivirus‑mediated microRNA‑26a overexpression in bone mesenchymal stem cells facilitates bone regeneration in bone defects of calvaria in mice.Mol Med Rep.
Zhang, Y., Wang, Z., Wang, Y., Li, L., Wu, Z., Ito, Y., Yang, X., and Zhang, P. (2018). A Novel Approach via Surface Modification of Degradable Polymers with Adhesive DOPA-IGF-1 for Neural Tissue Engineering.J Pharm Sci.

Pages